On-Demand Fireside Chat

Formulation and Delivery
of Spray Dried Biologics
for Nasal Dosage Forms.

Speakers:

Dr. Richard Johnson

Chief Scientific Officer

Dr Richard Johnson is the Founding Director and Chief Scientific Officer at Upperton Pharma Solutions, a UK-based Contract, Development and Manufacturing Organisation (CDMO) and graduated from Warwick University with a PhD Biochemistry. In 1994 he was part of a management buy-out team that founded Andaris Ltd, a research and development company exploiting the use of spray drying technology in the fields of diagnostic imaging and drug delivery. In 1999, Dr Johnson founded Upperton and has overseen significant growth and expansion over the past 25 years, specialising in spray drying and nasal drug development.

Lara Penn

Lara Penn

Senior Development Scientist II

Lara Penn is a Senior Development Scientist II at Upperton Pharma Solutions in Nottingham. She holds a BSc in Pharmaceutical Chemistry from the University of Leicester. With over five years of experience, Lara has progressed from Quality Control Scientist to senior roles in formulation and project development. She specialises in analytical testing, method validation, and formulation development of oral solid dosage forms. Lara applies a science-led approach to support efficient development and manufacturing under GMP. She is skilled in HPLC, UV-Vis, FTIR, dissolution testing, and preparing technical documentation and SOPs.

Let’s continue the conversation.
Set up a technical call with our experts below.

Download Our Fact Sheet: The New Rules of CDMO Partnerships

What Biotechs Should Be Looking For Next

Let's Talk.

Book a discovery call.

Speak with our team of experts and set up a discovery call to discuss your project in more detail.